Outpost Bio is decoding the hidden interactions that drive human biology. The company combines high-throughput assays of human-derived microbial communities with machine learning to build frontier models that reveal causal pathways - not just correlations. Headquartered in Boston and London, the company enables any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response - making human microbiology computable for the first time.
- Life Sciences
- London, United Kingdom
- £2.6m
- outpost.bio
- Update Information
More venture news
- 15 Apr 2026

LightcastLightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
EquityLife Sciences - 14 Apr 2026

HelicalHelical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
SeedLife Sciences - 31 Mar 2026

SemarionSemarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
EquityLife Sciences
